Journal of Tissue Engineering (Jul 2022)

Adipose tissue-derived microvascular fragments promote lymphangiogenesis in a murine lymphedema model

  • Florian S Frueh,
  • Laura Gassert,
  • Claudia Scheuer,
  • Andreas Müller,
  • Peter Fries,
  • Anne S Boewe,
  • Emmanuel Ampofo,
  • Claudia E Rübe,
  • Michael D Menger,
  • Matthias W Laschke

DOI
https://doi.org/10.1177/20417314221109957
Journal volume & issue
Vol. 13

Abstract

Read online

Chronic lymphedema after cancer treatment is common and there is still no cure for this disease. We herein investigated the lymphangiogenic capacity of adipose tissue-derived microvascular fragments (MVF), which contain stem cells and lymphatic vessel fragments. Secondary lymphedema was induced in the hindlimbs of C57BL/6J mice. Green fluorescence protein (GFP) + MVF were isolated from transgenic C57BL/6Tg (CAG-EGFP)1Osb/J mice, suspended in collagen hydrogel, and injected in the lymphadenectomy defect of wild-type animals. This crossover model allowed the detection of MVF-derived blood and lymphatic vessels after transplantation. The MVF group was compared with animals receiving collagen hydrogel only or a sham intervention. Lymphangiogenic effects were analyzed using volumetry, magnetic resonance (MR) lymphography, histology, and immunohistochemistry. MVF injection resulted in reduced hindlimb volumes when compared to non-treated controls. MR lymphography revealed lymphatic regeneration with reduced dermal backflow after MVF treatment. Finally, MVF transplantation promoted popliteal angiogenesis and lymphangiogenesis associated with a significantly increased microvessel and lymphatic vessel density. These findings indicate that MVF transplantation represents a promising approach to induce therapeutic lymphangiogenesis.